Purdue Pharma’s Creditors Vote Yes To Bankruptcy Deal Shielding Billionaire Owners From Future Opioid Lawsuits The deal, which the OxyContin-maker says is worth $10 billion, is to settle thousands of lawsuits against the company for its alleged role in fueling the opioid crisis.